← The Wire
TNXPNasdaq
Tonix Pharmaceuticals Holding Corp.
Pharmaceutical Preparations · NV · CIK 1430306
Tonix Pharmaceuticals develops and commercializes innovative therapies for CNS disorders, immunology, infectious diseases, and rare diseases
red 8-K · 90d
$181M
Market cap
$12.75
Last close
-3.6%
1D
+4.5%
5D
526K
Volume
Price · last 39 sessions-2.1%
May 4L $10.65 · H $15.74Jun 29
662
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KReg FD Disclosure · Company UpdateJun 29, 20268-KReg FD Disclosure · Company UpdateJun 8, 20268-KReg FD Disclosure · Company UpdateMay 27, 20268-KReg FD Disclosure · Company UpdateMay 15, 20268-KResults of OperationsMay 11, 202610-QQUARTERLY REPORTMay 11, 20268-KExecutive Change · Shareholder VoteMay 7, 20268-KReg FD Disclosure · Company UpdateMay 6, 20268-KResults of Operations · Company UpdateMay 1, 20268-KReg FD Disclosure · Company UpdateApr 29, 20268-KReg FD Disclosure · Company UpdateApr 23, 20268-KReg FD Disclosure · Company UpdateMar 31, 2026DEF 14ADEFINITIVE PROXY STATEMENTMar 30, 20268-KReg FD Disclosure · Company UpdateMar 26, 20268-KAuditor ChangeMar 18, 20268-KResults of OperationsMar 13, 202610-KANNUAL REPORTMar 12, 20268-KReg FD Disclosure · Company UpdateMar 10, 20268-KReg FD Disclosure · Company UpdateMar 3, 20268-KResults of Operations · Company UpdateFeb 3, 20268-KMaterial Agreement · Company UpdateDec 29, 2025424B5PROSPECTUS SUPPLEMENTDec 29, 20258-KReg FD Disclosure · Company UpdateDec 29, 20258-KReg FD Disclosure · Company UpdateDec 16, 20258-KReg FD Disclosure · Company UpdateDec 9, 20258-KReg FD Disclosure · Company UpdateNov 24, 2025424B5PROSPECTUS SUPPLEMENTNov 21, 20258-KMaterial Agreement · Company UpdateNov 21, 20258-KCompany UpdateNov 18, 20258-KReg FD Disclosure · Company UpdateNov 17, 202510-QQUARTERLY REPORTNov 10, 20258-KResults of OperationsNov 10, 20258-KResults of Operations · Company UpdateOct 27, 20258-KReg FD Disclosure · Company UpdateOct 22, 20258-KReg FD Disclosure · Company UpdateOct 7, 20258-KReg FD Disclosure · Company UpdateSep 30, 20258-KReg FD Disclosure · Company UpdateSep 29, 20258-KReg FD Disclosure · Company UpdateSep 18, 20258-KReg FD Disclosure · Company UpdateSep 17, 20258-KReg FD Disclosure · Company UpdateAug 18, 20258-KReg FD Disclosure · Company UpdateAug 15, 20258-KResults of OperationsAug 11, 202510-QQUARTERLY REPORTAug 11, 20258-KResults of Operations · Company UpdateJul 25, 20258-KReg FD Disclosure · Company UpdateJul 21, 20258-KReg FD Disclosure · Company UpdateJul 16, 20258-KReg FD Disclosure · Company UpdateJul 10, 20258-KReg FD Disclosure · Company UpdateJul 9, 20258-KReg FD Disclosure · Company UpdateJul 2, 20258-KReg FD Disclosure · Company UpdateJun 16, 20258-KExecutive Change · Company UpdateJun 13, 2025424B5PROSPECTUS SUPPLEMENTJun 11, 2025424B5PROSPECTUS SUPPLEMENTJun 11, 20258-KMaterial AgreementJun 11, 20258-KReg FD Disclosure · Company UpdateMay 21, 20258-KReg FD Disclosure · Company UpdateMay 14, 20258-KResults of OperationsMay 12, 202510-QQUARTERLY REPORTMay 12, 20258-KShareholder VoteMay 8, 20258-KReg FD Disclosure · Company UpdateApr 29, 20258-KResults of Operations · Company UpdateApr 25, 20258-KReg FD Disclosure · Company UpdateApr 24, 20258-KReg FD Disclosure · Company UpdateApr 9, 20258-KReg FD Disclosure · Company UpdateApr 1, 2025DEF 14ADEFINITIVE PROXY STATEMENTMar 31, 20258-KReg FD Disclosure · Company UpdateMar 24, 20258-KResults of OperationsMar 18, 202510-KANNUAL REPORTMar 18, 20258-KReg FD Disclosure · Company UpdateMar 10, 20258-KExecutive ChangeMar 4, 20258-KReg FD Disclosure · Company UpdateMar 4, 20258-KCompany UpdateFeb 21, 20258-KReg FD DisclosureFeb 7, 20258-KReg FD Disclosure · Company UpdateFeb 6, 20258-KExecutive Change · Reg FD DisclosureFeb 4, 20258-KAgreement Terminated · Results of OperationsFeb 3, 20258-KReg FD Disclosure · Company UpdateJan 8, 20258-KReg FD Disclosure · Company UpdateDec 23, 20248-KCompany UpdateDec 20, 2024424B5PROSPECTUSDec 20, 2024
Insider Activity
In the 90 days to Mar 18, 2026: 1 insider bought $223K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Lederman SethChief Executive Officer | Buy | 15,000 | $14.89 | $223K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance